Bio-Connect

LAG3 antibody [17B4] (Azide free)

GTX33931-00
GeneTex
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
TargetLAG3
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    LAG3 antibody [17B4] (Azide free)
  • Delivery Days Customer
    9
  • Antibody Specificity
    Recognizes human LAG-3.
  • Application Supplier Note
    IHC-Fr: . *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, Neutralisation/Blocking
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    17B4
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID3902
  • Target name
    LAG3
  • Target description
    lymphocyte activating 3
  • Target synonyms
    CD223; lymphocyte activation gene 3 protein; lymphocyte-activation gene 3
  • Host
    Mouse
  • Isotype
    IgG1
  • Protein IDP18627
  • Protein Name
    Lymphocyte activation gene 3 protein
  • Scientific Description
    Lymphocyte-activation protein 3 belongs to Ig superfamily and contains 4 extracellular Ig-like domains. The LAG3 gene contains 8 exons. The sequence data, exon/intron organization, and chromosomal localization all indicate a close relationship of LAG3 to CD4. [provided by RefSeq, Jul 2008]
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Human lymphocyte activation gene-3 molecules expressed by activated T cells deliver costimulation signal for dendritic cell activation. Casati C et al., 2008 Mar 15, J Immunol
    Read more
  • A soluble lymphocyte activation gene-3 (sLAG-3) protein as a prognostic factor in human breast cancer expressing estrogen or progesterone receptors. Triebel F et al., 2006 Apr 8, Cancer Lett
    Read more
  • The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells. Macon-Lemaitre L et al., 2005 Jun, Immunology
    Read more
  • Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway. Di Carlo E et al., 2005 Jan, J Pathol
    Read more
  • T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts. Demeure CE et al., 2001 Sep, Eur J Cancer
    Read more
  • CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling. Hannier S et al., 1998 Oct 15, J Immunol
    Read more
  • Characterization of the major histocompatibility complex class II binding site on LAG-3 protein. Huard B et al., 1997 May 27, Proc Natl Acad Sci U S A
    Read more
  • Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand. Huard B et al., 1994, Immunogenetics
    Read more
  • Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens. Baixeras E et al., 1992 Aug 1, J Exp Med
    Read more